We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.04B
AUM Growth
+$449M
Cap. Flow
+$66.9M
Cap. Flow %
0.95%
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
54
Reduced
51
Closed
9

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$37.6M
2
MDLZ icon
Mondelez International
MDLZ
+$11.6M
3
NKE icon
Nike
NKE
+$11.2M
4
CL icon
Colgate-Palmolive
CL
+$10.4M
5
CNC icon
Centene
CNC
+$9.46M

Sector Composition

Rank Sector Weight
1 Financials 27.87%
2 Healthcare 18.82%
3 Consumer Discretionary 16.92%
4 Communication Services 15.48%
5 Materials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
26
Mondelez International
MDLZ
$84.1B
$31.1M 0.44%
764,549
-273,196
-26% -$11.6M
CELG
27
DELISTED
Celgene Corp
CELG
$26.1M 0.37%
179,019
-5,044
-3% -$687K
AMGN icon
28
Amgen
AMGN
$212B
$20.6M 0.29%
110,716
-4,512
-4% -$799K
PFE icon
29
Pfizer
PFE
$144B
$19.6M 0.28%
579,045
-21,948
-4% -$705K
AGN
30
DELISTED
Allergan plc
AGN
$19.5M 0.28%
95,086
-3,704
-4% -$861K
DVAX
31
DELISTED
Dynavax Technologies
DVAX
$17.7M 0.25%
823,825
+155,610
+23% +$2.46M
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
$17.4M 0.25%
210,627
-12,933
-6% -$1.03M
BMY icon
33
Bristol-Myers Squibb
BMY
$129B
$16.4M 0.23%
257,031
-9,981
-4% -$583K
PRTK
34
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$16.2M 0.23%
645,100
+205,700
+47% +$4.79M
BIIB icon
35
Biogen
BIIB
$31.8B
$15.6M 0.22%
49,665
-15,710
-24% -$4.65M
INSM icon
36
Insmed
INSM
$22.7B
$14M 0.2%
447,429
+305,958
+216% +$5.83M
MRK icon
37
Merck
MRK
$322B
$12.9M 0.18%
210,456
-7,600
-3% -$461K
ABBV icon
38
AbbVie
ABBV
$470B
$12.7M 0.18%
143,271
-27,776
-16% -$2.11M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.09T
$12.7M 0.18%
260,380
-700
-0.3% -$33.2K
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
$11.5M 0.16%
81,944
-31,483
-28% -$4.28M
CI icon
41
Cigna
CI
$78.8B
$11M 0.16%
58,777
-38,101
-39% -$6.78M
BSX icon
42
Boston Scientific
BSX
$68.7B
$10.7M 0.15%
367,194
-14,278
-4% -$394K
LLY icon
43
Eli Lilly
LLY
$1.09T
$10.7M 0.15%
125,120
-5,364
-4% -$440K
SHPG
44
DELISTED
Shire pic
SHPG
$10.6M 0.15%
69,219
-2,626
-4% -$412K
HCA icon
45
HCA Healthcare
HCA
$90.9B
$10.4M 0.15%
130,618
-5,534
-4% -$445K
EW icon
46
Edwards Lifesciences
EW
$49.1B
$10.1M 0.14%
277,179
-11,607
-4% -$443K
GKOS icon
47
Glaukos
GKOS
$9.22B
$9.62M 0.14%
291,425
+33,594
+13% +$1.28M
CNC icon
48
Centene
CNC
$31.3B
$9.06M 0.13%
187,306
-219,782
-54% -$9.46M
INCY icon
49
Incyte
INCY
$25.4B
$8.87M 0.13%
75,941
-47,783
-39% -$6.05M
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$12B
$8.28M 0.12%
88,972
-14,809
-14% -$1.31M

Similar funds

C WorldWide Group's Q3 2017 Portfolio in Review

As of Q3 2017, C WorldWide Group held 135 positions worth $7.04B, up 6.8% from $6.59B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

C WorldWide Group's Q3 2017 filing shows 6 new, 54 increased, 51 reduced and 9 closed positions. Its largest new stake was Zimmer Biomet: 61,428 shares worth $6.98M. The largest sale was Home Depot, an estimated $37.6M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • C WorldWide Group's largest Q3 2017 buy was Zimmer Biomet: 61,428 shares worth $6.98M.
  • C WorldWide Group added most to Citigroup in Q3 2017, an estimated $52.2M increase.
  • C WorldWide Group's biggest Q3 2017 reduction was Home Depot, cutting an estimated $37.6M.
  • C WorldWide Group fully exited Nike in Q3 2017, selling an estimated $11.2M.
  • C WorldWide Group's ten largest holdings make up 69% of its $7.04B portfolio in Q3 2017.
  • C WorldWide Group opened 6 new positions and closed 9 in Q3 2017.
  • C WorldWide Group's portfolio value rose 6.8% quarter-over-quarter to $7.04B.

Based on C WorldWide Group's 13F filing for Q3 2017, filed 6 Nov 2017.